Literature DB >> 24432284

DNA vaccines: roles against diseases.

Kishwar Hayat Khan.   

Abstract

Vaccination is the most successful application of immunological principles to human health. Vaccine efficacy needs to be reviewed from time to time and its safety is an overriding consideration. DNA vaccines offer simple yet effective means of inducing broad-based immunity. These vaccines work by allowing the expression of the microbial antigen inside host cells that take up the plasmid. These vaccines function by generating the desired antigen inside the cells, with the advantage that this may facilitate presentation through the major histocompatibility complex. This review article is based on a literature survey and it describes the working and designing strategies of DNA vaccines. Advantages and disadvantages for this type of vaccines have also been explained, together with applications of DNA vaccines. DNA vaccines against cancer, tuberculosis, Edwardsiella tarda, HIV, anthrax, influenza, malaria, dengue, typhoid and other diseases were explored.

Entities:  

Keywords:  DNA vaccine; Vaccination; applications; diseases

Year:  2013        PMID: 24432284      PMCID: PMC3882840          DOI: 10.11599/germs.2013.1034

Source DB:  PubMed          Journal:  Germs        ISSN: 2248-2997


  63 in total

Review 1.  Progress in the development of DNA vaccines against foot-and-mouth disease.

Authors:  Veronica L Fowler; Paul V Barnett
Journal:  Expert Rev Vaccines       Date:  2012-04       Impact factor: 5.217

2.  Development of a DNA vaccine targeting Merkel cell polyomavirus.

Authors:  Qi Zeng; Bianca P Gomez; Raphael P Viscidi; Shiwen Peng; Liangmei He; Barbara Ma; T-C Wu; Chien-Fu Hung
Journal:  Vaccine       Date:  2011-12-29       Impact factor: 3.641

3.  Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes.

Authors:  Y H Chow; B L Chiang; Y L Lee; W K Chi; W C Lin; Y T Chen; M H Tao
Journal:  J Immunol       Date:  1998-02-01       Impact factor: 5.422

4.  DNA vaccine with α-galactosylceramide at prime phase enhances anti-tumor immunity after boosting with antigen-expressing dendritic cells.

Authors:  Daejin Kim; Chien-Fu Hung; T-C Wu; Yeong-Min Park
Journal:  Vaccine       Date:  2010-09-17       Impact factor: 3.641

Review 5.  Myonecrosis caused by Edwardsiella tarda: a case report and case series of extraintestinal E. tarda infections.

Authors:  E M Slaven; F A Lopez; S M Hart; C V Sanders
Journal:  Clin Infect Dis       Date:  2001-04-17       Impact factor: 9.079

6.  DNA vaccines in sheep: CTLA-4 mediated targeting and CpG motifs enhance immunogenicity in a DNA prime/protein boost strategy.

Authors:  Nicholas J Kennedy; Terry W Spithill; Jan Tennent; Paul R Wood; David Piedrafita
Journal:  Vaccine       Date:  2005-09-06       Impact factor: 3.641

7.  Gene vaccination with naked plasmid DNA: mechanism of CTL priming.

Authors:  M Corr; D J Lee; D A Carson; H Tighe
Journal:  J Exp Med       Date:  1996-10-01       Impact factor: 14.307

Review 8.  HPV & HPV vaccination: issues in developing countries.

Authors:  Mausumi Bharadwaj; Showket Hussain; Vilas Nasare; Bhudev C Das
Journal:  Indian J Med Res       Date:  2009-09       Impact factor: 2.375

Review 9.  FDA guidance on prophylactic DNA vaccines: analysis and recommendations.

Authors:  Dennis M Klinman; Sven Klaschik; Debra Tross; Hidekazu Shirota; Folkert Steinhagen
Journal:  Vaccine       Date:  2009-11-24       Impact factor: 3.641

10.  Risk analysis of an anthrax outbreak in cattle and humans of Sesheke district of Western Zambia.

Authors:  Hetron Mweemba Munang'andu; Fredrick Banda; Webster Chikampa; Stephen Mutoloki; Michelo Syakalima; Musso Munyeme
Journal:  Acta Trop       Date:  2012-08-02       Impact factor: 3.112

View more
  50 in total

1.  Novel antigen delivery systems.

Authors:  Maria Trovato; Piergiuseppe De Berardinis
Journal:  World J Virol       Date:  2015-08-12

2.  Systemic and Mucosal Immune Responses to Cryptosporidium-Vaccine Development.

Authors:  Jacob G Ludington; Honorine D Ward
Journal:  Curr Trop Med Rep       Date:  2015-09-01

3.  Digital-to-biological converter for on-demand production of biologics.

Authors:  Kent S Boles; Krishna Kannan; John Gill; Martina Felderman; Heather Gouvis; Bolyn Hubby; Kurt I Kamrud; J Craig Venter; Daniel G Gibson
Journal:  Nat Biotechnol       Date:  2017-05-29       Impact factor: 54.908

4.  Dissolving microneedles for DNA vaccination: Improving functionality via polymer characterization and RALA complexation.

Authors:  Grace Cole; Joanne McCaffrey; Ahlam A Ali; John W McBride; Cian M McCrudden; Eva M Vincente-Perez; Ryan F Donnelly; Helen O McCarthy
Journal:  Hum Vaccin Immunother       Date:  2016-11-15       Impact factor: 3.452

5.  The concurrent effects of azurin and Mammaglobin-A genes in inhibition of breast cancer progression and immune system stimulation in cancerous BALB/c mice.

Authors:  Payam Ghasemi-Dehkordi; Abbas Doosti; Mohammad-Saeid Jami
Journal:  3 Biotech       Date:  2019-06-18       Impact factor: 2.406

Review 6.  Nucleic Acid Vaccine Platform for DENGUE and ZIKA Flaviviruses.

Authors:  Jarin Taslem Mourosi; Ayobami Awe; Swati Jain; Himanshu Batra
Journal:  Vaccines (Basel)       Date:  2022-05-24

Review 7.  Nucleic Acids as Novel Therapeutic Modalities to Address Multiple Sclerosis Onset and Progression.

Authors:  Hussein Baharlooi; Amir Hossein Mansourabadi; Moein Minbashi Moeini; Leila Mohamed Khosroshahi; Maryam Azimi
Journal:  Cell Mol Neurobiol       Date:  2021-10-25       Impact factor: 4.231

8.  The Immunization of Protoscolices P29 DNA Vaccine on Experimental Cystic Echinococosis in Balb/c Mice.

Authors:  Zahra Gharibi; Mahmoud Rahdar; Majid Pirestani; Mehdi Tavalla; Mohammad-Reza Tabandeh
Journal:  Acta Parasitol       Date:  2021-04-03       Impact factor: 1.440

Review 9.  An overview on Leishmania vaccines: A narrative review article.

Authors:  Hossein Rezvan; Mohammad Moafi
Journal:  Vet Res Forum       Date:  2015-03-15       Impact factor: 1.054

10.  An Intramuscular DNA Vaccine for SARS-CoV-2 Decreases Viral Lung Load but Not Lung Pathology in Syrian Hamsters.

Authors:  Shanna S Leventhal; Chad Clancy; Jesse Erasmus; Heinz Feldmann; David W Hawman
Journal:  Microorganisms       Date:  2021-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.